Translational Allergic Immunopathology Unit, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Department of Immunology Discovery, Genentech Inc., South San Francisco, USA.
Curr Opin Immunol. 2021 Oct;72:94-106. doi: 10.1016/j.coi.2021.04.001. Epub 2021 Apr 28.
Dysregulated mast cell-mediated inflammation and/or activation have been linked to a number of human diseases, including asthma, anaphylaxis, chronic spontaneous urticaria, and mast cell activation syndromes. As a major mast cell granule protein, tryptase is a biomarker commonly used in clinical practice to diagnose mast cell-associated disorders and -mediated reactions, but its mechanistic roles in disease pathogenesis remains incompletely understood. Here, we summarize recent advances in the understanding of human tryptase genetics and the effects that different genetic composition may have on the quaternary structure of tetrameric mature tryptases. We also discuss how these differences may impact clinical phenotypes including allergic inflammation, immediate hypersensitivity, and others seen in patients with mast cell-associated disorders. With the increased application of next-generation sequencing, we foresee that human genetic approaches will be a major focus of understanding human tryptase functions in various human mast cell disorders and in new therapeutic development.
紊乱的肥大细胞介导的炎症和/或激活与许多人类疾病有关,包括哮喘、过敏反应、慢性自发性荨麻疹和肥大细胞激活综合征。作为主要的肥大细胞颗粒蛋白,类胰蛋白酶是一种在临床实践中常用于诊断肥大细胞相关疾病和介导反应的生物标志物,但它在疾病发病机制中的作用机制仍不完全清楚。在这里,我们总结了近年来对人类类胰蛋白酶遗传学的理解的进展,以及不同的遗传组成可能对四聚体成熟类胰蛋白酶的四级结构产生的影响。我们还讨论了这些差异如何影响临床表型,包括过敏炎症、即刻超敏反应和其他在与肥大细胞相关的疾病患者中观察到的表型。随着下一代测序的应用增加,我们预计人类遗传方法将成为理解各种人类肥大细胞疾病中和新的治疗开发中人类类胰蛋白酶功能的主要焦点。